asia pacific autotransfusion devices Market

Market Introduction

The autotransfusion process involves the reinfusion of the patient's blood. Blood is collected from the peritoneal cavity or thorax region. The process can be carried out before surgery or during and after the surgery using the autotransfusion system. Medical procedures, like joint replacement, spinal surgeries, and cardiac, among others, require autotransfusion. It helps to reduce the risk of infection, and also it eliminates the problems and complications associated with the banking and administration of homologous donor blood. It helps to prevent the transmission of transfusion-related blood-borne diseases in patients.

Market Overview and Dynamics

The Asia-Pacific Autotransfusion Devices market is expected to reach US$   330.88 million by 2027 from US$   231.27 million in 2019. The market is expected  to grow with a CAGR of 4.7% from 2020 to 2027. The growth of the market is driven by the factors such as, involvement of rare blood groups, and rising prevalence of chronic diseases. Whereas, the market is likely to have negative impact due to the, risks associated with autotransfusion.

Key Market Segments

In terms of type, the product segment held the largest share of the market in 2019. However, the Accessories segment is estimated to register the highest CAGR in the market during the forecast period. In terms of the application , the cardiac surgeries segment held the largest share of the market in 2019, while the organ transplantation segment is also estimated to register the highest CAGR in the market during the forecast period. In terms of the end-user the hospitals segment held the largest share of the market in 2019 and is expected to register the highest CAGR in the market during the forecast period

Major Sources and Companies Listed

Some of the major primary and secondary sources for Autotransfusion Devices Market included in the report are, American Health Association, Ministry of Health and Family Welfare, World Health Organization, National, and Centers for Disease Control and Prevention

Reasons to buy the report

• To understand the Asia-Pacific autotransfusion Devices market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for Asia-Pacific Autotransfusion Devices market
• Efficiently plan M&A and partnership deals in Asia-Pacific Autotransfusion Devices market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments of Asia-Pacific Autotransfusion Devices market.
• Obtain market revenue forecast for market by various segments from 2019 to 2027 in Asia-Pacific
  

Autotransfusion Devices Market

By Type

• Product

1. • Intraoperative Autotransfusion Systems
   • Postoperative Autotransfusion Systems
   • Dual-Mode Autotransfusion Systems

• Accessories

By Application

• Cardiac Surgeries
• Orthopaedic Surgeries
• Organ Transplantation
• Trauma Procedures
• Others

By End User

• Hospitals
• Specialty Clinics
• Ambulatory Surgery Centers

By Country

• Asia Pacific (APAC)

• China
• India
• Japan
• Australia
• South Korea

Company Profiles

• Zimmer Biomet
• BD
• Teleflex Incorporated
• Fresenius SE & Co. KGaA
• Medtronic